Building Blocks of Life, AlphaFold and AI Drug Development

In this episode of Agents of Tech, we dive into the groundbreaking advancements in AI and biotechnology with a focus on AlphaFold 3, the revolutionary AI model developed by Google DeepMind. Before AlphaFold developers Demis Hassabis and John Jumper were awarded the 2024 Nobel Prize in Chemistry for their work, this AI system had already been making waves by predicting 3D protein structures with unprecedented accuracy.Join hosts Stephen Horn and Autria Godfrey as they explore the profound impact AlphaFold is having on science, from understanding the building blocks of life to accelerating drug discovery. We speak with Dr. Luke Yates, Assistant Professor at the University of Sussex, who explains how AlphaFold 3 is changing the landscape of biological research. We also hear from Dr. Kyle Rohde of the University of Central Florida, whose lab is using AI to speed up the development of new antibiotics, particularly for drug-resistant tuberculosis.Recorded prior to the Nobel Prize announcement, this episode offers an insightful look into the future of AI-driven discoveries in biology, medicine, and beyond. Don’t miss out on this fascinating discussion!Subscribe to Agents of Tech for more on the latest breakthroughs in science and technology. #AlphaFold #AIinBiology #NobelPrize2024 #DrugDiscovery #Biotechnology #AgentsOfTech #DeepMind #ScienceBreakthroughs #Antibiotics #ProteinFolding #AIinMedicine #DeepLearning #AlphaFold3 #FutureOfBiotech #AIInnovation #SciencePodcast #AIRevolution #BiomedicalResearch #Genomics #AIForGood #DrugDevelopment #TechForHealth #ArtificialIntelligence #CuttingEdgeTech #NobelPrizeScience #MedicalBreakthroughs #TechInBiology. 00:00 - Welcome to Agents of Tech00:13 - Hosts Introduction00:19 - Exploring Life's Building Blocks & Antibiotic Development00:54 - Upcoming Guests & Topics01:00 - Interview with Dr. Luke Yates on AlphaFold 303:20 - The Significance of Protein Folding06:12 - Impact of AlphaFold on Disease Research10:30 - Challenges in Drug Discovery13:05 - Open-Source Debate on AlphaFold16:10 - Ethical Concerns of AI in Biology18:00 - Interview with Dr. Kyle Rohde on TB Drug Discovery20:30 - How Multidrug-Resistant TB Complicates Treatment23:40 - AI and Target-Based Screening for New Antibiotics27:40 - The Future of AI-Driven Drug Discovery31:00 - Closing Remarks & Next Episode Preview32:00 - Subscribe to Agents of Tech

There are no comments yet.

Please log in to write the first comment.